1Blake G J, Ridker P M. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89: 763--771.
2Libby P. Changing concepts of atherogenesis. J Internal Med, 2000, 247: 349--358.
3Kabbani S S, Watkins M W, Holoch P A, et al. Platelet reactivity in coronary ostial blood: A reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy. J Thromb Thrombolysis, 2001,12: 171--176.
4Atalar E, Aytemir K, Haznedaroglu I, et al. Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol, 2001, 78:69--73.
5Kayikcioglu M, Can L, Meto-Erdem N, et al. Soluble p-selectin and the success of thrombolysis in acute myocardial infarction. Int J Cardiol, 2001,79: 223--229.
6Itoh T, Nakai K, Ono M, et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker p-selectin?Coron Artery Dis, 1995,6: 645--650.
7Crea F, Biasucci L M, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol, 1997, 80(5A): 10E--16E.
8Merten M, Thiagarajan P. P-selectin expression on platelet determines size and stability of platelet aggregates. Circulation, 2000,102: 1931--1936.
9Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction.Thromb Res, 2001, 104: 197--205.
10Bienvenu J G, Tanguay J F, Theore J F, et al. Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation,2001, 103: 1128--1134.
